Literature DB >> 21656110

[Uncommon cutaneous ulcerative and systemic sarcoidosis. Successful treatment with hydroxychloroquine and compression therapy].

D Meyersburg1, M P Schön, H P Bertsch, C S Seitz.   

Abstract

Sarcoidosis is a granulomatous multisystemic disease of unclear etiology, which can affect any organ. The cutaneous manifestations are variable, but ulcerative cutaneous sarcoidosis is very rare. One must rule out other granulomatous skin diseases, especially necrobiosis lipoidica. There is no standarized therapy; usually an interdisciplinary approach over years taking multiple side effects into consideration is needed. A 58-year-old woman with a long history of cutaneous, nodal and pulmonary sarcoidosis suddenly developed ulcerations within the disseminated skin lesions on her legs. The combination of systemic hydroxychloroquine and modern wound management lead to complete healing of the ulcers and a significant improvement in the remaining skin lesions.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21656110     DOI: 10.1007/s00105-010-2120-7

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  13 in total

1.  Significant improvement in ulcerative necrobiosis lipoidica with hydroxychloroquine.

Authors:  Mukaddes Kavala; Sibel Sudogan; Ilkin Zindanci; Emek Kocaturk; Burce Can; Zafer Turkoglu; Sumeyye Altintas
Journal:  Int J Dermatol       Date:  2010-04       Impact factor: 2.736

Review 2.  [Therapeutic strategies for cutaneous sarcoidosis].

Authors:  Heidi Bäcker; Michael Landthaler; Rolf-Markus Szeimies
Journal:  J Dtsch Dermatol Ges       Date:  2005-04       Impact factor: 5.584

Review 3.  Ulcerative sarcoidosis: case report and review of the Japanese literature.

Authors:  Yoshiro Ichiki; Yasuo Kitajima
Journal:  Acta Derm Venereol       Date:  2008       Impact factor: 4.437

Review 4.  Sarcoidosis.

Authors:  J C English; P J Patel; K E Greer
Journal:  J Am Acad Dermatol       Date:  2001-05       Impact factor: 11.527

Review 5.  Ulcerative sarcoidosis successfully treated with apligraf.

Authors:  M Streit; L M Böhlen; L R Braathen
Journal:  Dermatology       Date:  2001       Impact factor: 5.366

6.  Necrobiosis lipoidica-like skin lesions in systemic sarcoidosis.

Authors:  K Igawa; R Maruyama; T Satoh; H Yokozeki; I Katayama; K Nishioka
Journal:  J Dermatol       Date:  1998-10       Impact factor: 4.005

7.  [Successful treatment of skin and lung sarcoidosis with fumaric acid ester].

Authors:  R Gutzmer; A Kapp; T Werfel
Journal:  Hautarzt       Date:  2004-06       Impact factor: 0.751

8.  Clinicopathologic features of ulcerative-atrophic sarcoidosis.

Authors:  Simon S Yoo; Daniel Mimouni; Olga V Nikolskaia; David J Kouba; Daniel N Sauder; Carlos H Nousari
Journal:  Int J Dermatol       Date:  2004-02       Impact factor: 2.736

9.  [Successful therapy of ulcerated necrobiosis lipoidica non diabeticorum with cyclosporine A].

Authors:  E Aslan; A Körber; S Grabbe; J Dissemond
Journal:  Hautarzt       Date:  2007-08       Impact factor: 0.751

10.  Use of antimalarials in dermatology.

Authors:  Falk R Ochsendorf
Journal:  J Dtsch Dermatol Ges       Date:  2010-07-29       Impact factor: 5.584

View more
  3 in total

Review 1.  Nonsteroidal therapy of sarcoidosis.

Authors:  Peter Korsten; Mehdi Mirsaeidi; Nadera J Sweiss
Journal:  Curr Opin Pulm Med       Date:  2013-09       Impact factor: 3.155

Review 2.  [Cutaneous manifestations of sarcoidosis].

Authors:  K Amschler; C S Seitz
Journal:  Z Rheumatol       Date:  2017-06       Impact factor: 1.372

3.  [Cutaneous and pulmonary sarcoidosis. Successful therapy with fumaric acid esters].

Authors:  A Wolter; M Müller; B Völker; M Gehring; F Caldarone; A Kapp; T Werfel; U Raap
Journal:  Hautarzt       Date:  2012-10       Impact factor: 0.751

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.